Medical support and surgery of the failing heart: Levosimendan

Scandinavian Journal of Surgery

Volumn 96, Issue 2, 2007, Pages 121-124

  Toller, Wolfgang ^a   Knez, I ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acute heart failure; Calcium sensitizer; Catecholamines; Levosimendan; Perioperative; Phosphodiesterase inhibitors

Indexed keywords

ADRENALIN; CALCIUM SENSITIZER; CATECHOLAMINE; DOBUTAMINE; DOPAMINE; LEVOSIMENDAN; NORADRENALIN; PHOSPHODIESTERASE INHIBITOR;

ALGORITHM; BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM BLOOD LEVEL; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; HYPOTENSION; INOTROPISM; PERIOPERATIVE PERIOD; REVIEW; SIDE EFFECT; STUNNED HEART MUSCLE; SUDDEN DEATH; VASODILATATION;

EID: 34347268838     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690709600206     Document Type: Review

References (17)

1. Thackray S, Easthaugh J, Freemantle N, Cleland JG: The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure - a meta-regression analysis. Eur J Heart Fail 2002;4:515-529
2. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froerilich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith J, S. C., Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B: ACC/AHA 2006 Guideline Update on Perioperative Cardiovascular Evaluation for Noncardiac Surgery: Focused Update on Perioperative Beta-Blocker Therapy. Circulation 2006; 113:2662-2674
3. Toller WG, Stranz C: Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 2006;104:556-569
4. Cuffe MS, Califf RM, Adams KF, Jr., Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002; 287: 1541-1547
5. Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM, Gheorghiade M, O'Connor CM: Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 2003; 41:997-1003
6. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L: Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002;360: 196-202
7. Nanas JN, Papazoglou P, Tsagalou EP, Ntalianis A, Tsolakis E, Terrovitis JV, Kanakakis J, Nanas SN, Alexopoulos GP, Anastasiou-Nana MI: Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone. Am J Cardiol 2005;95:768-771
8. Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC: Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 1999;34:219-228
9. Lilleberg J, Nieminen MS, Akkila J, Heikkila L, Kuitunen A, Lehtonen L, Verkkala K, Mattila S, Salmenpera M: Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J 1998; 19:660-668
10. Barisin S, Husedzinovic I, Sonicki Z, Bradic N, Barisin A, Tonkovic D: Levosimendan in off-pump coronary artery bypass: a four-times masked controlled study. J Cardiovasc Pharmacol 2004;44:703-708
11. Sonntag S, Sundberg S, Lehtonen LA, Kleber FX: The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol 2004; 43:2177-2182
12. Ellger BM, Zahn PK, Van Aken HK, Schmidt C, Brussel T: Levosimendan: a promising treatment for myocardial stunning? Anaesthesia 2006;61:61-63
13. Garcia-Gonzalez MJ, Dominguez-Rodriguez A: Effect of levosimendan treatment of myocardial stunning and low-output syndrome after cardiac surgery. Rev Esp Cardiol 2006;59: 851-852
14. Lechner E, Moosbauer W, Pinter M, Mair R, Tulzer G: Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate. Pediatr Crit Care Med 2007; 8:61-63
15. Moiseyev VS, Poder P, Andrejevs N, Ruda MY, Golikov AP, Lazebnik LB, Kobalava ZD, Lehtonen LA, Laine T, Nieminen MS, Lie KI: Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J 2002;23: 1422-1432
16. ATP channels. Anesth Analg 2000; 90:5-11
17. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Moreno R, Singer M, Singh S, Tendera M, Thygesen K: Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416